The cardiorenal syndrome.

Area of Science:

• Cardiology
• Nephrology
• Internal Medicine

Background:

• The term 'cardiorenal syndrome' (CRS) lacks a consistent definition, hindering understanding of heart-kidney interactions.
• CRS encompasses a spectrum of conditions where dysfunction in one organ impacts the other, necessitating a clear classification.

Purpose of the Study:

• To define and classify cardiorenal syndrome (CRS) into distinct subtypes.
• To emphasize the bidirectional pathophysiological relationship between cardiac and renal systems.

Main Methods:

• Review and synthesis of existing literature on cardiorenal interactions.
• Development of a 5-subtype classification system for CRS based on primary pathology, time course, and affected organ.

Main Results:

• Cardiorenal syndrome (CRS) is classified into 5 subtypes: Type I (acute heart to kidney), Type II (chronic heart to kidney), Type III (acute kidney to heart), Type IV (chronic kidney to heart), and Type V (systemic disease affecting both).
• Each subtype describes specific pathophysiological pathways and clinical presentations.
• Biomarkers are crucial for characterizing subtypes and guiding treatment.

Conclusions:

• A standardized 5-subtype classification of cardiorenal syndrome (CRS) provides a framework for understanding complex heart-kidney interactions.
• This classification aids in patient identification, management strategies, and future clinical trial design.
• Further research into specific pathophysiological mechanisms and biomarker utility is warranted.